Return to study ST002167 main page

Download data matrix(Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase (AML cells) Other NEGATIVE ION MODE)

Download data matrix(Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase (AML cells) Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Other NEGATIVE ION MODE4T1_1Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Other NEGATIVE ION MODE4T1_2Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Other NEGATIVE ION MODE4T1_3Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Other NEGATIVE ION MODE4T1_4Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcont_1Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcont_2Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcont_3Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcontrol_1Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcontrol_2Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcontrol_3Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODEcontrol_4Culture conditions:Control | Treatment:No treatmentpeak area
Other NEGATIVE ION MODETNF200_1Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Other NEGATIVE ION MODETNF200_2Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Other NEGATIVE ION MODETNF200_3Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Other NEGATIVE ION MODETNF20_1Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
Other NEGATIVE ION MODETNF20_2Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
Other NEGATIVE ION MODETNF20_3Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODE4T1_1Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODE4T1_2Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODE4T1_3Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODE4T1_4Culture conditions:4T1-conditioned media | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcont_1Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcont_2Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcont_3Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcontrol_1Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcontrol_2Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcontrol_3Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODEcontrol_4Culture conditions:Control | Treatment:No treatmentpeak area
Reversed phase POSITIVE ION MODETNF200_1Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODETNF200_2Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODETNF200_3Culture conditions:Control | Treatment:TNFalpha (200 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODETNF20_1Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODETNF20_2Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
Reversed phase POSITIVE ION MODETNF20_3Culture conditions:Control | Treatment:TNFalpha (20 ng/mL) treatmentpeak area
  logo